Hepatoprotective Potential of Herbal Bioactive Components: Phytochemistry, Mechanism, and Therapeutic Insights

Abstract

Liver disease has emerged as a major global health challenge, accounting for millions of deaths annually and placing a substantial burden on healthcare systems worldwide. Its increasing prevalence is closely linked to excessive alcohol consumption, long-term drug exposure, industrial and environmental chemicals, viral infections, and metabolic disorders such as obesity and diabetes. Although synthetic hepatoprotective drugs are widely prescribed, their clinical application is often limited by adverse effects, high toxicity risk, variable therapeutic efficacy, and limited ability to promote liver regeneration. These shortcomings have intensified scientific interest in natural, plant-based hepatoprotective agents as safer and more effective alternatives. Herbal bioactive compounds—including flavonoids, alkaloids, phenolic acids, terpenoids, and saponins— exhibit a wide spectrum of pharmacological properties such as antioxidant, anti-inflammatory, anti-fibrotic, immunomodulatory, and cytoprotective activities. These compounds contribute to the restoration of liver architecture, enhancement of detoxification pathways, reduction of oxidative stress, and normalization of liver enzymes and biomarkers. Compared to many synthetic drugs, herbal agents often demonstrate improved safety profiles and better patient tolerance. However, despite promising preclinical and clinical findings, significant gaps remain in understanding their molecular mechanisms of action, bioavailability, pharmacokinetics, and long-term clinical efficacy. This review systematically evaluates evidence from both clinical trials and experimental studies on 13 major natural products, including Liv 52, probiotics, phospholipids, vitamin D, artichoke, berberine, and turmeric. It examines their botanical sources, active constituents, therapeutic applications, and underlying mechanisms of hepatoprotection in liver disorders such as non-alcoholic fatty liver disease (NAFLD), hepatitis, alcoholic liver disease, and drug-induced hepatotoxicity. Furthermore, this review critically assesses the quality of existing data and highlights the urgent need for standardized dosing, rigorous toxicity evaluation, and large-scale randomized clinical trials to fully harness the therapeutic potential of herbal medicines in liver disease management.